Table 3.
Patients and tumor characteristics referred by PP, for evaluation in the HNOC-MDT represented in absolute number and percentage of the total.
| Variable | Mean in y (min max) | |
|---|---|---|
| Age | 65 (15-92) | |
| Gender | n (%) | |
| Male | 335 (65%) | |
| Female | 180 (35%) | |
| Tumor site | n (%) | |
| Oral cavity | 185 (35.9%) | |
| Larynx | 129 (25%) | |
| Oropharynx | 89 (17.3%) | |
| Hypopharynx | 29 (5.6%) | |
| Nasal cavity | 27 (5.2%) | |
| Salivary glands | 23 (4.5%) | |
| Unknown primary | 19 (3.7%) | |
| Nasopharynx | 3 (0.6%) | |
| Other | 11 (2.1%) | |
| Disease | n (%) | |
| Primary | 450 (87.4%) | |
| Second primary | 29 (5.6%) | |
| Recurrent/residual | 36 (7%) | |
| Overall comorbidity score (ACE-27) | n (%) | |
| 0 (None) | 154 (29.9%) | |
| 1 (Mild) | 197 (38.3%) | |
| 2 (Moderate) | 97 (18.8%) | |
| 3 (Severe) | 67 (13%) | |
| T-classification | n (%) | |
| Tx | 0 (0%) | |
| T0 | 18 (3.5%) | |
| Tis | 7 (1.4%) | |
| T1 | 137 (26.6%) | |
| T2 | 116 (22.5%) | |
| T3 | 76 (14.8%) | |
| T4 | 115 (22.3%) | |
| N-classification | n (%) | |
| Nx | 8 (1.6%) | |
| N0 | 312 (60.6%) | |
| N1 | 48 (9.3%) | |
| N2 | 90 (17.5%) | |
| N3 | 11 (2.1%) | |
| M-classification | ||
| Mx | 9 (1.7%) | |
| M0 | 460 (89.3%) | |
| M1 | 0 (0%) | |
| Missing | 46 (8,9%) | |